Edwine Barasa
Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.Orangi S, Ojal J, Brand SP, Orlendo C, Kairu A, Aziza R, Ogero M, Agweyu A, Warimwe GM, Uyoga S, Otieno E, Ochola-Oyier LI, Agoti CN, Kasera K, Amoth P, Mwangangi M, Aman R, Ng'ang'a W, Adetifa IM, Scott JAG, Bejon P, Keeling MJ, Flasche S, Nokes DJ, Barasa E
BMJ Glob Health, (2022). 7:e009430
A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand.Briones J, Wang Y, Prawjaeng J, Wee HL, Kairu A, Orangi S, Barasa E, Teerawattananon Y
Int J Public Health, (2022). 67:1604854
Experiences of and response to the COVID-19 pandemic at private retail pharmacies in Kenya: a mixed-methods study.Mugo PM, Mumbi A, Munene D, Nzinga J, Molyneux S, Barasa E, PSK COVID- Response Taskforce
BMJ Open, (2022). 12:e058688
Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: A retrospective genomic study.Agoti CN, Ochola-Oyier LI, Dellicour S, Mohammed KS, Lambisia AW, de Laurent ZR, Morobe JM, Mburu MW, Omuoyo DO, Ongera EM, Ndwiga L, Maitha E, Kitole B, Suleiman T, Mwakinangu M, Nyambu JK, Otieno J, Salim B, Musyoki J, Murunga N, Otieno E, Kiiru JN, Kasera K, Amoth P, Mwangangi M, Aman R, Kinyanjui S, Warimwe G, Phan M, Agweyu A, Cotten M, Barasa E, Tsofa B, Nokes DJ, Bejon P, Githinji G
Elife, (2022). 11:e71703
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.Oortwijn W, Husereau D, Abelson J, Barasa E, Bayani DD, Canuto Santos V, Culyer A, Facey K, Grainger D, Kieslich K, Ollendorf D, Pichon-Riviere A, Sandman L, Strammiello V, Teerawattananon Y
Value Health, (2022). 25:869-886
Is Performance-Based Financing A Pathway to Strategic Purchasing in Sub-Saharan Africa? A Synthesis of the Evidence.Waithaka D, Cashin C, Barasa E
Health Syst Reform, (2022). 8:e2068231
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.Oortwijn W, Husereau D, Abelson J, Barasa E, Bayani DD, Santos VC, Culyer A, Facey K, Grainger D, Kieslich K, Ollendorf D, Pichon-Riviere A, Sandman L, Strammiello V, Teerawattananon Y
Int J Technol Assess Health Care, (2022). 38:e37
Experience of Kenyan researchers and policy-makers with knowledge translation during COVID-19: a qualitative interview study.Guleid FH, Njeru A, Kiptim J, Kamuya DM, Okiro E, Tsofa B, English M, Molyneux S, Kariuki D, Barasa E
BMJ Open, (2022). 12:e059501
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.Nyagwange J, Ndwiga L, Muteru K, Wamae K, Tuju J, Testing Team C, Kutima B, Gitonga J, Karanja H, Mugo D, Kasera K, Amoth P, Murunga N, Babu L, Otieno E, Githinji G, Nokes DJ, Tsofa B, Orindi B, Barasa E, Warimwe G, Agoti CN, Bejon P, Ochola-Oyier LI
Wellcome Open Res, (2022). 7:69
Applying the Strategic Health Purchasing Progress Tracking Framework: Lessons from Nine African Countries.Gatome-Munyua A, Sieleunou I, Barasa E, Ssengooba F, Issa K, Musange S, Osoro O, Makawia S, Boyi-Hounsou C, Amporfu E, Ezenwaka U
Health Syst Reform, (2022). 8:e2051796
Examining the unit costs of COVID-19 vaccine delivery in Kenya.Orangi S, Kairu A, Ngatia A, Ojal J, Barasa E
BMC Health Serv Res, (2022). 22:439
Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.Ferrari G, Torres-Rueda S, Chirwa E, Gibbs A, Orangi S, Barasa E, Tawiah T, Dwommoh Prah RK, Hitimana R, Daviaud E, Kapapa E, Dunkle K, Heise L, Stern E, Chatterji S, Omondi B, Ogum Alangea D, Karmaliani R, Maqbool Ahmed Khuwaja H, Jewkes R, Watts C, Vassall A
PLoS Med, (2022). 19:e1003827
Scaling up the primary health integrated care project for chronic conditions in Kenya: study protocol for an implementation research project.Nolte E, Kamano JH, Naanyu V, Etyang A, Gasparrini A, Hanson K, Koros H, Mugo R, Murphy A, Oyando R, Pliakas T, Were V, Willis R, Barasa E, Perel P
BMJ Open, (2022). 12:e056261
On the resilience of health systems: A methodological exploration across countries in the WHO African Region.Karamagi HC, Titi-Ofei R, Kipruto HK, Seydi AB, Droti B, Talisuna A, Tsofa B, Saikat S, Schmets G, Barasa E, Tumusiime P, Makubalo L, Cabore JW, Moeti M
PLoS One, (2022). 17:e0261904
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.Etyang AO, Lucinde R, Karanja H, Kalu C, Mugo D, Nyagwange J, Gitonga J, Tuju J, Wanjiku P, Karani A, Mutua S, Maroko H, Nzomo E, Maitha E, Kamuri E, Kaugiria T, Weru J, Ochola LB, Kilimo N, Charo S, Emukule N, Moracha W, Mukabi D, Okuku R, Ogutu M, Angujo B, Otiende M, Bottomley C, Otieno E, Ndwiga L, Nyaguara A, Voller S, Agoti CN, Nokes DJ, Ochola-Oyier LI, Aman R, Amoth P, Mwangangi M, Kasera K, Ng'ang'a W, Adetifa IMO, Wangeci Kagucia E, Gallagher K, Uyoga S, Tsofa B, Barasa E, Bejon P, Scott JAG, Agweyu A, Warimwe GM
Clin Infect Dis, (2022). 74:288-293
The policy and legal environment surrounding HIV prevention through community pharmacies in Kenya.Mugo P, Munene D, Molyneux S, Barasa E
The 42nd Annual Pharmaceutical Society of Kenya Conference, (2022). :
The policy and legal environment surrounding HIV prevention through community pharmacies in Kenya.Mugo P, Munene D, Molyneux S, Barasa E
The 42nd Annual Pharmaceutical Society of Kenya Conference, (2022). :
The hidden financial burden of healthcare: a systematic literature review of informal payments in Sub-Saharan Africa.Kabia E, Goodman C, Balabanova D, Muraya K, Molyneux S, Barasa E
Wellcome Open Res, (2021). 6:297
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data.Ojal J, Brand SPC, Were V, Okiro EA, Kombe IK, Mburu C, Aziza R, Ogero M, Agweyu A, Warimwe GM, Uyoga S, Adetifa IMO, Scott JAG, Otieno E, Ochola-Oyier LI, Agoti CN, Kasera K, Amoth P, Mwangangi M, Aman R, Ng'ang'a W, Tsofa B, Bejon P, Barasa E, Keeling MJ, Nokes DJ
Wellcome Open Res, (2021). 6:127
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya.Kagucia EW, Gitonga JN, Kalu C, Ochomo E, Ochieng B, Kuya N, Karani A, Nyagwange J, Karia B, Mugo D, Karanja HK, Tuju J, Mutiso A, Maroko H, Okubi L, Maitha E, Ajuck H, Mukabi D, Moracha W, Bulimu D, Andanje N, Aman R, Mwangangi M, Amoth P, Kasera K, Ng'ang'a W, Nyaguara A, Voller S, Otiende M, Bottomley C, Agoti CN, Ochola-Oyier LI, Adetifa IMO, Etyang AO, Gallagher KE, Uyoga S, Barasa E, Bejon P, Tsofa B, Agweyu A, Warimwe GM, Scott JAG, Magarini Sub-County TDA SARS-CoV-2 Serosurveillance Team, The Busia County TDA SARS-CoV-Serosurveillance Team
Open Forum Infect Dis, (2021). 8:ofab314
